...
首页> 外文期刊>Surgical Endoscopy >Laparoscopic management of type II Mirizzi syndrome
【24h】

Laparoscopic management of type II Mirizzi syndrome

机译:II型Mirizzi综合征的腹腔镜管理

获取原文
获取原文并翻译 | 示例

摘要

Background Mirizzi syndrome is an uncommon complication of longstanding gallstone disease. Pre-operative diagnosis is challenging, and to date, there is no consensus on the standard management for this condition. Until recently open cholecystectomy was the standard of care for type II Mirizzi syndrome (McSherry classification). The objective of this study was to assess the incidence and management of type II Mirizzi syndrome in patients with proven or suspected choledocholithiasis undergoing laparoscopic common bile duct (CBD) exploration and present our experience in the laparoscopic management of this rare condition over the last 21 years. Methods Prospective data collection of eleven cases of type II Mirizzi syndrome amongst a series of 425 laparoscopic bile duct explorations was performed between 1998 and 2019. Demographic, clinical, diagnostic, intra-operative, and post-operative data were recorded. Results The incidence of type II Mirizzi syndrome was 2.6% in 425 laparoscopic CBD explorations. All operations were completed laparoscopically with closure of the defect over a decompressed CBD (T-tube n = 3, antegrade stent n = 5, transcystic drain n = 2), and in one case a non-drained duct was closed with Endoloop. Stone clearance rate was 100% (11 cases). In two patients the transinfundibular approach was used in conjunction with holmium laser lithotripsy to enable choledochoscopy and successful stone clearance. Three patients were complicated in the post-operative period with bile leak (n = 2) and lower respiratory tract infection (n = 1). An incidental gallbladder carcinoma was found in one patient. Conclusion Laparoscopic management of type II Mirizzi syndrome is feasible and safe when performed by experienced laparoscopic foregut surgeons. Laparoscopy and choledochoscopy can be combined with novel approaches and techniques to increase the likelihood of treatment success.
机译:背景技术Mirizzi综合征是一种罕见的胆结石病的并发症。术前诊断是具有挑战性的,迄今为止,对这种情况的标准管理没有共识。直到最近开放的胆囊切除术是II型Mirizzi综合征(McSherry分类)的护理标准。本研究的目的是评估患有腹腔镜常见胆管(CBD)勘探的经过验证或可疑的胆总管胆管症(CBD)探索的患者II型Mirizzia综合征的发病率和管理,并在过去21年中展示了我们在腹腔镜管理的腹腔镜管理中的经验。方法在1998年至2019年间,在一系列425腹腔镜胆管探索中进行II型Mirizzi综合征11型案例的前瞻性数据收集。记录了人口统计学,临床,诊断,术语和术后数据。结果425型腹腔镜CBD勘探中II型Mirizzi综合征的发病率为2.6%。腹腔镜仔细地完成所有操作,闭合缩短的CBD(T-Tube n = 3,缩短支架n = 5,转生液排放N = 2),并且在一种情况下用Endoloop关闭非排水管道。石清关率为100%(11例)。在两名患者中,Transinfibuld方法与Holmium Laser Lithotripsy一起使用,以实现胆固型和成功的石灰。三个患者在术后时期复杂,胆汁泄漏(n = 2)和低呼吸道感染(n = 1)。在一个患者中发现了偶然的胆囊癌。结论II型Mirizzi综合征的腹腔镜管理是由经验丰富的腹腔镜前置外科医生进行的可行和安全。腹腔镜和胆总管镜可以与新的方法和技术相结合,以增加治疗成功的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号